文献速递脊柱脊髓外科神经肿瘤

脊柱转移瘤立体定向放射外科术前椎体后凸成形术的安全性与效用:临床与剂量学分析

Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis.
PubMed 文献 · J Neurosurg Spine · 2017-11-03

该回顾性研究分析了2012年1月至2015年7月间164例患者192个接受单次脊柱立体定向放射外科(SRS)治疗的脊柱转移瘤治疗节段,其中17个(8.8%)在SRS前接受了椎体后凸成形术。结果显示,椎体后凸成形术后SRS在无硬膜外脊髓压迫的病例中是安全的,不改变放疗疗效,也不妨碍医生遵循SRS计划和勾画指南;剂量学分析显示两组间无显著差异。

要点

  • 在无硬膜外脊髓压迫的脊柱转移瘤患者中,SRS前进行骨水泥强化稳定是安全的。
  • 骨水泥强化不改变SRS的疗效,也不妨碍遵循SRS计划和勾画指南。
  • 骨水泥所致未校正电子密度值的剂量学误差不显著。

核心结论

  • 在无硬膜外脊髓压迫的病例中,SRS前进行骨水泥强化稳定是安全的,不改变放疗疗效,也不妨碍医生遵循SRS计划和勾画指南。

研究设计与样本

  • 回顾性分析2012年1月至2015年7月期间在一家大型三级癌症中心接受单次SRS(单独或椎体后凸成形术后)的所有患者的病历、影像报告和图像。
  • 共纳入164例患者的192个治疗节段,其中17个(8.8%)在SRS前接受了椎体后凸成形术。
  • 通过实验测定兆伏光子束穿过椎体后凸成形术骨水泥模体时的衰减,以测量聚甲基丙烯酸甲酯所致的光子散射,并重新计算校正后的电子密度值并与未校正值比较。

主要发现

  • 在192个治疗节段中,分析时发现4个(2%)出现局部肿瘤复发或进展;4例局部失败中1例在SRS前接受了椎体后凸成形术,该复发发生在SRS后18个月,背景为广泛系统性病变和脊柱肿瘤进展。
  • 该病例的剂量学回顾显示治疗剂量低于队列其余患者的平均水平。
  • 椎体后凸成形术后SRS组与队列其余患者之间的剂量学分析无显著差异。
  • 对聚甲基丙烯酸甲酯的初步分析显示,未校正电子密度值所致的剂量学误差不显著。
  • 从椎体后凸成形术到SRS的中位时间为22天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The aim of this study was to evaluate the safety and efficacy of kyphoplasty treatment prior to spine stereotactic radiosurgery (SRS) in patients with spine metastases. METHODS A retrospective review of charts, radiology reports, and images was performed for all patients who received SRS (single fraction; either standalone or post-kyphoplasty) at a large tertiary cancer center between January 2012 and July 2015. Patient and tumor variables were documented, as well as treatment planning data and dosimetry. To measure the photon scatter due to polymethyl methacrylate, megavolt photon beam attenuation was determined experimentally as it passed through a kyphoplasty cement phantom. Corrected electron density values were recalculated and compared with uncorrected values. RESULTS Of 192 treatment levels in 164 unique patients who underwent single-fraction SRS, 17 (8.8%) were treated with kyphoplasty prior to radiation delivery to the index level. The median time from kyphoplasty to SRS was 22 days. Four of 192 treatments (2%) demonstrated local tumor recurrence or progression at the time of analysis. Of the 4 local failures, 1 patient had kyphoplasty prior to SRS. This recurrence occurred 18 months after SRS in the setting of widespread systemic disease and spinal tumor progression. Dosimetric review demonstrated a lower than average treatment dose for this case compared with the rest of the cohort. There were no significant differences in dosimetry analysis between the group of patients who underwent kyphoplasty prior to SRS and the remaining patients in the cohort. A preliminary analysis of polymethyl methacrylate showed that dosimetric errors due to uncorrected electron density values were insignificant. CONCLUSIONS In cases without epidural spinal cord compression, stabilization with cement augmentation prior to SRS is safe and does not alter the efficacy of the radiation or preclude physicians from adhering to SRS planning and contouring guidelines.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Barzilai O, DiStefano N, Lis E, et al. Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis. J Neurosurg Spine. 2017. PMID: 29087812. doi:10.3171/2017.5.SPINE1746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。